Patents by Inventor Ashley E. Fenwick

Ashley E. Fenwick has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Serotonin 5-HT2B inhibitory compounds
    Patent number: 12209084
    Abstract: The invention describes novel serotonin c5-HT2B receptor antagonists of Formula (1), and pharmaceutically acceptable salts thereof; wherein Ring A, L, X, X?, R3, R4, m and n are as defined herein. Also described are compositions comprising a Formula (1) compound, or a pharmaceutically acceptable salt thereof; and methods of using the compounds, or a pharmaceutically acceptable salt thereof, for the treatment of myxomatous mitral valve disease (MMVD), congestive heart failure (CHF) and/or asymptomatic heart failure in animals, preferably is a canine.
    Type: Grant
    Filed: July 22, 2022
    Date of Patent: January 28, 2025
    Assignee: Zoetis Services LLC
    Inventors: Richard A. Ewin, Ashley E. Fenwick, Govindan Subramanian
  • SEROTONIN 5-HT2B INHIBITORY COMPOUNDS
    Publication number: 20230071039
    Abstract: The invention describes novel serotonin c5-HT2B receptor antagonists of Formula (1), and pharmaceutically acceptable salts thereof; wherein Ring A, L, X, X?, R3, R4, m and n are as defined herein. Also described are compositions comprising a Formula (1) compound, or a pharmaceutically acceptable salt thereof; and methods of using the compounds, or a pharmaceutically acceptable salt thereof, for the treatment of myxomatous mitral valve disease (MMVD), congestive heart failure (CHF) and/or asymptomatic heart failure in animals, preferably is a canine.
    Type: Application
    Filed: July 22, 2022
    Publication date: March 9, 2023
    Inventors: Richard A. Ewin, Ashley E. Fenwick, Govindan Subramanian
  • Protease inhibitors
    Publication number: 20020082426
    Abstract: 1
    Type: Application
    Filed: February 27, 2002
    Publication date: June 27, 2002
    Applicant: SmithKline Beecham Corporation
    Inventors: Ashley E. Fenwick, Andrew D. Gribble, Robert W. Marquis, Jason Witherington
  • Xanthine derivatives
    Patent number: 5409934
    Type: Grant
    Filed: July 7, 1993
    Date of Patent: April 25, 1995
    Inventors: David G. Smith, Derek R. Buckle, Ashley E. Fenwick